文献速递疼痛医学

产业资助与研究地点对脊髓电刺激随机对照试验结果的影响:系统综述与荟萃分析

Does industry funding and study location impact findings from randomized controlled trials of spinal cord stimulation? A systematic review and meta-analysis.
PubMed 文献 · Reg Anesth Pain Med · 2024-04-02

该系统综述与荟萃分析纳入17项随机对照试验共1823例神经病理性疼痛患者,评估产业资助和研究地点对脊髓电刺激(SCS)疗效报告的影响。结果显示,SCS与常规护理比较,产业资助与非产业资助研究在6个月疼痛强度上无显著亚组差异(p=0.48,中等确定性证据);但高频SCS与低频SCS比较中,产业资助研究显示高频SCS有统计学显著优势,而无资助研究未显示差异(低确定性证据)。

要点

  • SCS与常规护理比较,产业资助与非产业资助研究的6个月疼痛强度无显著亚组差异。
  • 高频SCS与低频SCS比较的疼痛强度结果可能受产业资助影响。
  • 产业资助研究显示高频SCS优于低频SCS,无资助研究未显示差异(低确定性证据)。

核心结论

  • SCS与常规护理的所有结局在产业资助与非产业资助研究间无显著差异。
  • 高频SCS与低频SCS比较的疼痛强度评分及较基线变化似乎受产业资助影响。

研究设计与样本

  • 系统综述与随机效应荟萃分析,检索MEDLINE、CENTRAL、EMBASE和WikiStim数据库至2022年9月。
  • 纳入平行组随机对照试验,评估SCS用于神经病理性疼痛患者,共纳入17项RCT的29篇报告(1823例参与者)。
  • 按资助来源和研究地点进行亚组荟萃分析,使用Cochrane RoB 2.0工具评估偏倚风险。

主要发现

  • SCS与常规护理比较,6个月疼痛强度评分的亚组差异检验无统计学意义(p=0.48,中等确定性证据):无资助或未披露资助的合并均数差为-1.96(95%CI -3.23至-0.69;I2=0%,τ2=0);产业资助的合并均数差为-2.70(95%CI -4.29至-1.11;95%PI -8.75至3.35,I2=97%,τ2=2.96);非产业资助的均数差为-3.09(95%CI -4.47至-1.72;95%PI、I2和τ2不适用)。
  • 高频SCS与低频SCS比较,产业资助研究显示高频SCS有统计学显著优势,而无资助研究显示两者无差异(低确定性证据)。

临床怎么用

  • 解读SCS随机对照试验结果时需考虑资助来源,尤其在高频与低频SCS比较中。
  • SCS与常规护理的比较结果在不同资助来源研究中一致,支持其疗效证据的稳健性。

局限性

  • 高频与低频SCS比较的资助亚组分析证据确定性低。
  • 产业资助研究的异质性高(I2=97%,τ2=2.96)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND/IMPORTANCE: Concerns have been raised that effects observed in studies of spinal cord stimulation (SCS) funded by industry have not been replicated in non-industry-funded studies and that findings may differ based on geographical location where the study was conducted. OBJECTIVE: To investigate the impact of industry funding and geographical location on pain intensity, function, health-related quality of life and adverse events reported in randomized controlled trials (RCTs) of SCS. EVIDENCE REVIEW: Systematic review conducted using MEDLINE, CENTRAL, EMBASE and WikiStim databases until September 2022. Parallel-group RCTs evaluating SCS for patients with neuropathic pain were included. Results of studies were combined in random-effects meta-analysis using the generic-inverse variance method. Subgroup meta-analyses were conducted according to funding source and study location. Risk of bias was assessed using Cochrane RoB 2.0 tool. FINDINGS: Twenty-nine reports of 17 RCTs (1823 participants) were included. For the comparison of SCS with usual care, test for subgroup differences indicate no significant differences (p=0.48, moderate certainty evidence) in pain intensity score at 6 months for studies with no funding or funding not disclosed (pooled mean difference (MD) -1.96 (95% CI -3.23 to -0.69; 95% prediction interval (PI) not estimable, I2=0%, τ2=0)), industry funding (pooled MD -2.70 (95% CI -4.29 to -1.11; 95% PI -8.75 to 3.35, I2=97%, τ2=2.96) or non-industry funding (MD -3.09 (95% CI -4.47 to -1.72); 95% PI, I2 and τ2 not applicable). Studies with industry funding for the comparison of high-frequency SCS (HF-SCS) with low-frequency SCS (LF-SCS) showed statistically significant advantages for HF-SCS compared to LF-SCS while studies with no funding showed no differences between HF-SCS and LF-SCS (low certainty evidence). CONCLUSION: All outcomes of SCS versus usual care were not significantly different between studies funded by industry and those independent from industry. Pain intensity score and change in pain intensity from baseline for comparisons of HF-SCS to LF-SCS seem to be impacted by industry funding.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. Eldabe S, Nevitt S, Copley S, et al. Does industry funding and study location impact findings from randomized controlled trials of spinal cord stimulation? A systematic review and meta-analysis. Reg Anesth Pain Med. 2024. PMID: 37611944. doi:10.1136/rapm-2023-104674

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。